We summarized recent studies on the physiological interactions between GPCR and leptin signaling, offering insights into the role of GPCR signaling in enhancing leptin responsiveness, primarily focusing on GPCR- and leptin-based therapeutic strategies for the treatment of obesity (Table 1). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.